Siddharth Kogilwaimath, MD FIDSA
banner
hivdocsk.bsky.social
Siddharth Kogilwaimath, MD FIDSA
@hivdocsk.bsky.social
Infectious Diseases Doc/Associate Professor at UTSW with an interest in HIV. Canadian. Nomad. Views, my own. He/Him/his. 🇨🇦🇮🇳🇧🇳🇲🇾

📍Dallas 🇺🇸
Me when someone explains the US billing codes, vs me, 5 minutes later. #IDmeme
February 19, 2025 at 10:57 PM
Thank you @sustainabil-id.bsky.social for inviting me and my colleague, Dr. Govind, to speak on the issue of #HIV and #sustainability. Forced us to delve into this. There are few studies and observations but largely an area we dont talk much about. If anyone is interested, DM me! Love to collaborate
January 12, 2025 at 4:34 PM
Fried egg maggi, irani chai (not in pic) and reviewing missed lectures from #HIVGlasgow2024.
November 20, 2024 at 9:29 PM
Adios Glasgow. Found community in times of chaos. Soul recharged. Definitely one of my favorite conferences. ❤️ #HIVGlasgow2024
November 14, 2024 at 8:41 AM
- Must be culturally sensitive.
- Ask women what they want!!
November 11, 2024 at 4:34 PM
Models of Care.
- Care integration
- Home based care: might be an option but might be tricky
- community based

Need a multimorbidity framework.
#HIVGlasgow2024
November 11, 2024 at 4:33 PM
Research on older women with HIV- limited data with CV risk
- women have diff types of MI
- CT angiography may undeestimate cardiac risk in Women with HIV
- we need to do more to address the research gaps as women are underrepresented in research; stop talking about it and do it!!
#HIVGlasgow2024
November 11, 2024 at 4:30 PM
Prof Gilleece on whether women with HIV are adequately being supported!!
- women have different care needs; physiologically, biologically (inflm at various life stages) at various stages of their lives
#HIVGlasgow
November 11, 2024 at 4:25 PM
Royal Free- the Sage Clinic. Carousel model with multiple team members. Increasingly community focus.
November 11, 2024 at 4:21 PM
Models of Care in the UK.
- HIV clinic led models: outpt clinics with HIV specialist + team using Comprehensive geriatric approach. Adv: patients known to team. May be resource heavy.
- community based
- virtual based
- primary care based

#HIVGlasgow2024
November 11, 2024 at 4:19 PM
2022 Glasgow Manifesto. Need for targetted research with community invl.
November 11, 2024 at 4:14 PM
@tristanjbarber.bsky.social Models of care Older PWH.
- multiple issues must be addressed to avoid falling through the gaps
- 5.7 million older PWH; higher burden in LMIC
- call to action on this to avoid more morbidity and mortality: some are easier, some are harder. Loneliness is a big factor.
November 11, 2024 at 4:13 PM
November 11, 2024 at 4:10 PM
- Diseases cluster.
- hard to find data for comorbidity patterns across the world.
- data gaps
#HIVGlasgow2024
November 11, 2024 at 4:09 PM
November 11, 2024 at 4:06 PM
Prof Sabin:
- increasing age of PWH due to improvements in ART
- increasing comorbidities adjusted for age/gender/residence location
- comorbidity burden in PWH is like 5 years older in those without HIV
- trends of mortality: reduced AIDS related but ⬆️ non-AIDS
November 11, 2024 at 4:03 PM
Next up: Supporting an Older Population of PWH or at risk for HIV!
Dr Guaraldi:
- older PWH arw not minorities
- OPWH are heterogenous
- we must realign our services.
- focus not on disease; but on health and well-being. Must fight ageism.

#HIVGlasgow2024
November 11, 2024 at 3:59 PM
The I-know-you-from-Twitter-but we’re-now-on-BlueSky meeting with the brilliant @brendacrabtreer.bsky.social ❤️ #HIVGlasgow2024
November 11, 2024 at 3:21 PM
- similar side-effect btwn dtg/3tc vs 3dr
-
November 11, 2024 at 2:22 PM
DOLCE:
- had many with baseline high VL
- high efficacy and similar time to VS
- virologic success goes down with dtg/3tc in those with high HIV VL but similar to 3dr!
November 11, 2024 at 2:21 PM
Pedro Cahn with dtg/3tc in those with ARV naive and CD4 <200. Results from the DOLCE study. Phase 4, open-label.

#HIVGlasgow2024
November 11, 2024 at 2:15 PM
Cant keep up.. eek 😬
November 11, 2024 at 2:10 PM
Qweekly:
- PWH preferred longer intervals
- 6 drugs in dev; LEN/ISL insti free regimen

#HIVGlasgow2024
November 11, 2024 at 2:03 PM
Qdaily drugs pipeline:
- LEN/BIC combo
- lower dose ISL with lower T cell toxicity; studies restarted with DOR.
November 11, 2024 at 2:00 PM
Prof Jose Arribas with New ART:
- shift towards LA-ART despite low risk for resistance
November 11, 2024 at 1:55 PM